Figures
Fig 5 is uploaded incorrectly. Please see the correct Fig 5 here.
C57B/6 mice were given 10 μg polyI:C o.p. on days 0–2. On either days 0–2 (group A), days 1–2 (group B) or day 2 (group C), mice were also given vehicle or 700 μg/kg budesonide o.p.. On D3, 0.2 mg 4kDa FITC-dextran was instilled o.p. and 1hr later BALF and blood were harvested. A-B) Total protein and albumin levels in BALF were assessed via Bradford and ELISA respectively. C-D) FITC-dextran levels in BALF and serum were analyzed using a fluorescent plate reader. E-F) Neutrophils were assessed via cytospin and H&E staining, and CXCL1 was quantified via ELISA. Data are mean ± standard deviation. One way ANOVA followed by unpaired Tukey’s multiple comparisons test. * p <0.05, **p<0.01, *p<0.001.
Reference
Citation: Rimmer C, Hetelekides S, Eliseeva SI, Georas SN, Veazey JM (2024) Correction: Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge. PLoS ONE 19(7): e0306666. https://doi.org/10.1371/journal.pone.0306666
Published: July 1, 2024
Copyright: © 2024 Rimmer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.